Literature DB >> 19625402

Human immunodeficiency virus type 1 Vpr modulates cellular expression of UNG2 via a negative transcriptional effect.

Christelle Langevin1, Priscilla Maidou-Peindara, Per Arne Aas, Guillaume Jacquot, Marit Otterlei, Geir Slupphaug, Serge Benichou.   

Abstract

It was recently reported that human immunodeficiency virus type 1 (HIV-1) Vpr induced the proteasomal degradation of the nuclear UNG2 enzyme for efficient virus replication. We confirm here that HIV-1 infection and Vpr expression reduce the level of endogenous UNG2, but this effect is not reverted by treatment with the proteasome inhibitor MG132. Moreover, this reduction is not mediated by Vpr binding to UNG2 and is independent of the Vpr-induced G(2) arrest. Finally, we show that Vpr influences the UNG2 promoter without affecting UNG1 gene expression. These data indicate that the Vpr-induced decrease of UNG2 level is mainly related to a transcriptional effect.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19625402      PMCID: PMC2748015          DOI: 10.1128/JVI.02654-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  HIV-1 nuclear import: in search of a leader.

Authors:  M I Bukrinsky; O K Haffar
Journal:  Front Biosci       Date:  1999-10-15

Review 2.  HIV-1 Vpr: mechanisms of G2 arrest and apoptosis.

Authors:  Joshua L Andersen; Erwann Le Rouzic; Vicente Planelles
Journal:  Exp Mol Pathol       Date:  2008-04-25       Impact factor: 3.362

Review 3.  Uracil in DNA--occurrence, consequences and repair.

Authors:  Hans E Krokan; Finn Drabløs; Geir Slupphaug
Journal:  Oncogene       Date:  2002-12-16       Impact factor: 9.867

4.  Analysis of uracil-DNA glycosylases from the murine Ung gene reveals differential expression in tissues and in embryonic development and a subcellular sorting pattern that differs from the human homologues.

Authors:  H Nilsen; K S Steinsbekk; M Otterlei; G Slupphaug; P A Aas; H E Krokan
Journal:  Nucleic Acids Res       Date:  2000-06-15       Impact factor: 16.971

5.  The interaction of vpr with uracil DNA glycosylase modulates the human immunodeficiency virus type 1 In vivo mutation rate.

Authors:  L M Mansky; S Preveral; L Selig; R Benarous; S Benichou
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

6.  Human immunodeficiency virus type 1 Vpr protein is incorporated into the virion in significantly smaller amounts than gag and is phosphorylated in infected cells.

Authors:  B Müller; U Tessmer; U Schubert; H G Kräusslich
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

7.  Assembly with the Cul4A-DDB1DCAF1 ubiquitin ligase protects HIV-1 Vpr from proteasomal degradation.

Authors:  Erwann Le Rouzic; Marina Morel; Diana Ayinde; Nadia Belaïdouni; Justine Letienne; Catherine Transy; Florence Margottin-Goguet
Journal:  J Biol Chem       Date:  2008-06-04       Impact factor: 5.157

8.  DDB1 and Cul4A are required for human immunodeficiency virus type 1 Vpr-induced G2 arrest.

Authors:  Lindi Tan; Elana Ehrlich; Xiao-Fang Yu
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

9.  Localization of HIV-1 Vpr to the nuclear envelope: impact on Vpr functions and virus replication in macrophages.

Authors:  Guillaume Jacquot; Erwann Le Rouzic; Annie David; Julie Mazzolini; Jérôme Bouchet; Serge Bouaziz; Florence Niedergang; Gianfranco Pancino; Serge Benichou
Journal:  Retrovirology       Date:  2007-11-26       Impact factor: 4.602

10.  HIV-1 Vpr activates the G2 checkpoint through manipulation of the ubiquitin proteasome system.

Authors:  Jason L DeHart; Erik S Zimmerman; Orly Ardon; Carlos M R Monteiro-Filho; Enrique R Argañaraz; Vicente Planelles
Journal:  Virol J       Date:  2007-06-08       Impact factor: 4.099

View more
  20 in total

1.  HIV-1 Vpr loads uracil DNA glycosylase-2 onto DCAF1, a substrate recognition subunit of a cullin 4A-ring E3 ubiquitin ligase for proteasome-dependent degradation.

Authors:  Jinwoo Ahn; Thomas Vu; Zach Novince; Jennifer Guerrero-Santoro; Vesna Rapic-Otrin; Angela M Gronenborn
Journal:  J Biol Chem       Date:  2010-09-24       Impact factor: 5.157

2.  Damage control: how HIV survives the editor APOBEC3G.

Authors:  J Ludovic Croxford; Stephan Gasser
Journal:  Nat Immunol       Date:  2011-09-20       Impact factor: 25.606

3.  Diverse fates of uracilated HIV-1 DNA during infection of myeloid lineage cells.

Authors:  Erik C Hansen; Monica Ransom; Jay R Hesselberth; Nina N Hosmane; Adam A Capoferri; Katherine M Bruner; Ross A Pollack; Hao Zhang; Michael Bradley Drummond; Janet M Siliciano; Robert Siliciano; James T Stivers
Journal:  Elife       Date:  2016-09-20       Impact factor: 8.140

4.  Cullin4A and cullin4B are interchangeable for HIV Vpr and Vpx action through the CRL4 ubiquitin ligase complex.

Authors:  Hamayun John Sharifi; Andrea K M Furuya; Robert M Jellinger; Michael D Nekorchuk; Carlos M C de Noronha
Journal:  J Virol       Date:  2014-04-09       Impact factor: 5.103

5.  HIV-1 viral protein R downregulates Ebp1 and stabilizes p53 in glioblastoma U87MG cells.

Authors:  S Zhang; B Zhang; X Xu; L Wang; X Feng; Q Wang; H Huang; J Wu; P Li; J Wang
Journal:  Clin Transl Oncol       Date:  2013-07-05       Impact factor: 3.405

6.  Recruitment of the nuclear form of uracil DNA glycosylase into virus particles participates in the full infectivity of HIV-1.

Authors:  Carolin A Guenzel; Cécile Hérate; Erwann Le Rouzic; Priscilla Maidou-Peindara; Holly A Sadler; Marie-Christine Rouyez; Louis M Mansky; Serge Benichou
Journal:  J Virol       Date:  2011-12-14       Impact factor: 5.103

7.  Uracil DNA glycosylase initiates degradation of HIV-1 cDNA containing misincorporated dUTP and prevents viral integration.

Authors:  Amy F Weil; Devlina Ghosh; Yan Zhou; Lauren Seiple; Moira A McMahon; Adam M Spivak; Robert F Siliciano; James T Stivers
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-22       Impact factor: 11.205

8.  The HIV-1 protein Vpr targets the endoribonuclease Dicer for proteasomal degradation to boost macrophage infection.

Authors:  Laurieann Casey Klockow; Hamayun J Sharifi; Xiaoyun Wen; Meg Flagg; Andrea K M Furuya; Michael Nekorchuk; Carlos M C de Noronha
Journal:  Virology       Date:  2013-07-09       Impact factor: 3.616

9.  Uracil DNA N-glycosylase promotes assembly of human centromere protein A.

Authors:  Samantha G Zeitlin; Brian R Chapados; Norman M Baker; Caroline Tai; Geir Slupphaug; Jean Y J Wang
Journal:  PLoS One       Date:  2011-03-02       Impact factor: 3.240

10.  Mutation rates and intrinsic fidelity of retroviral reverse transcriptases.

Authors:  Luis Menéndez-Arias
Journal:  Viruses       Date:  2009-12-04       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.